These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38612618)

  • 41. Exome Sequencing Identifies a Novel LMNA Splice-Site Mutation and Multigenic Heterozygosity of Potential Modifiers in a Family with Sick Sinus Syndrome, Dilated Cardiomyopathy, and Sudden Cardiac Death.
    Zaragoza MV; Fung L; Jensen E; Oh F; Cung K; McCarthy LA; Tran CK; Hoang V; Hakim SA; Grosberg A
    PLoS One; 2016; 11(5):e0155421. PubMed ID: 27182706
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relevance of Titin Missense and Non-Frameshifting Insertions/Deletions Variants in Dilated Cardiomyopathy.
    Akinrinade O; Heliö T; Lekanne Deprez RH; Jongbloed JDH; Boven LG; van den Berg MP; Pinto YM; Alastalo TP; Myllykangas S; Spaendonck-Zwarts KV; van Tintelen JP; van der Zwaag PA; Koskenvuo J
    Sci Rep; 2019 Mar; 9(1):4093. PubMed ID: 30858397
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional characterization of novel alpha-helical rod domain desmin (DES) pathogenic variants associated with dilated cardiomyopathy, atrioventricular block and a risk for sudden cardiac death.
    Fischer B; Dittmann S; Brodehl A; Unger A; Stallmeyer B; Paul M; Seebohm G; Kayser A; Peischard S; Linke WA; Milting H; Schulze-Bahr E
    Int J Cardiol; 2021 Apr; 329():167-174. PubMed ID: 33373648
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic Basis of Childhood Cardiomyopathy.
    Bagnall RD; Singer ES; Wacker J; Nowak N; Ingles J; King I; Macciocca I; Crowe J; Ronan A; Weintraub RG; Semsarian C
    Circ Genom Precis Med; 2022 Dec; 15(6):e003686. PubMed ID: 36252119
    [TBL] [Abstract][Full Text] [Related]  

  • 45. No variants in the cardiac actin gene in Finnish patients with dilated or hypertrophic cardiomyopathy.
    Kärkkäinen S; Peuhkurinen K; Jääskeläinen P; Miettinen R; Kärkkäinen P; Kuusisto J; Laakso M
    Am Heart J; 2002 Jun; 143(6):E6. PubMed ID: 12075240
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sudden Unexpected Death of Infantile Dilated Cardiomyopathy with JPH2 and PKD1 Gene Variants.
    Miura A; Kondo H; Yamamoto T; Okumura Y; Nishio H
    Int Heart J; 2020 Sep; 61(5):1079-1083. PubMed ID: 32879264
    [TBL] [Abstract][Full Text] [Related]  

  • 47. X-linked dilated cardiomyopathy: the important role of genetic tests and imaging in the early diagnosis and treatment.
    Tsalamandris S; Oikonomou E; Vogiatzi G; Miliou A; Lazaros G; Georgakopoulos C; Gialafos E; Sideris S; Vlachopoulos C; Tousoulis D
    Future Cardiol; 2020 Nov; 16(6):629-634. PubMed ID: 32508136
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bi-allelic missense disease-causing variants in RPL3L associate neonatal dilated cardiomyopathy with muscle-specific ribosome biogenesis.
    Ganapathi M; Argyriou L; Martínez-Azorín F; Morlot S; Yigit G; Lee TM; Auber B; von Gise A; Petrey DS; Thiele H; Cyganek L; Sabater-Molina M; Ahimaz P; Cabezas-Herrera J; Sorlí-García M; Zibat A; Siegelin MD; Burfeind P; Buchovecky CM; Hasenfuss G; Honig B; Li Y; Iglesias AD; Wollnik B
    Hum Genet; 2020 Nov; 139(11):1443-1454. PubMed ID: 32514796
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Implications of Genetic Testing in Dilated Cardiomyopathy.
    Verdonschot JAJ; Hazebroek MR; Krapels IPC; Henkens MTHM; Raafs A; Wang P; Merken JJ; Claes GRF; Vanhoutte EK; van den Wijngaard A; Heymans SRB; Brunner HG
    Circ Genom Precis Med; 2020 Oct; 13(5):476-487. PubMed ID: 32880476
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Massive parallel sequencing questions the pathogenic role of missense variants in dilated cardiomyopathy.
    Dalin MG; Engström PG; Ivarsson EG; Unneberg P; Light S; Schaufelberger M; Gilljam T; Andersson B; Bergo MO
    Int J Cardiol; 2017 Feb; 228():742-748. PubMed ID: 27886618
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of uncertain significance genetic variants with myocardial mechanics and morphometrics in patients with nonischemic dilated cardiomyopathy.
    Mėlinytė-Ankudavičė K; Šukys M; Kasputytė G; Krikštolaitis R; Ereminienė E; Galnaitienė G; Mizarienė V; Šakalytė G; Krilavičius T; Jurkevičius R
    BMC Cardiovasc Disord; 2024 Apr; 24(1):224. PubMed ID: 38664609
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Considering complexity in the genetic evaluation of dilated cardiomyopathy.
    Jordan E; Hershberger RE
    Heart; 2021 Jan; 107(2):106-112. PubMed ID: 33109712
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genotype and Cardiac Outcomes in Pediatric Dilated Cardiomyopathy.
    Khan RS; Pahl E; Dellefave-Castillo L; Rychlik K; Ing A; Yap KL; Brew C; Johnston JR; McNally EM; Webster G
    J Am Heart Assoc; 2022 Jan; 11(1):e022854. PubMed ID: 34935411
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical characterisation of a novel
    Kean AC; Helm BM; Vatta M; Ayers MD; Parent JJ; Darragh RK
    Cardiol Young; 2019 Oct; 29(10):1257-1263. PubMed ID: 31477192
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pathogenic Variants Associated With Dilated Cardiomyopathy Predict Outcome in Pediatric Myocarditis.
    Seidel F; Holtgrewe M; Al-Wakeel-Marquard N; Opgen-Rhein B; Dartsch J; Herbst C; Beule D; Pickardt T; Klingel K; Messroghli D; Berger F; Schubert S; Kühnisch J; Klaassen S
    Circ Genom Precis Med; 2021 Aug; 14(4):e003250. PubMed ID: 34213952
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical characteristics of heart failure with reduced ejection fraction patients with rare pathogenic variants in dilated cardiomyopathy-associated genes: A subgroup analysis of the PARADIGM-HF trial.
    Barat A; Chen CW; Patel-Murray N; McMurray JJV; Packer M; Solomon SD; Desai AS; Rouleau JL; Zile MR; Attari Z; Zhang C; Xu H; Hartman N; Hon C; Healey M; Chutkow W; O'Donnell CJ; Jacob J; Lefkowitz M; Mendelson MM; Wandel S; Yates D; Gimpelewicz C
    Eur J Heart Fail; 2023 Aug; 25(8):1256-1266. PubMed ID: 37191081
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular characterization of Portuguese patients with dilated cardiomyopathy.
    Sousa A; Canedo P; Azevedo O; Lopes L; Pinho T; Baixia M; Rocha-Gonçalves F; Gonçalves L; Cardoso JS; Machado JC; Martins E;
    Rev Port Cardiol (Engl Ed); 2019 Feb; 38(2):129-139. PubMed ID: 30871747
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel likely pathogenic variant in the FBXO32 gene associated with dilated cardiomyopathy according to whole‑exome sequencing.
    Ghasemi S; Mahdavi M; Maleki M; Salahshourifar I; Kalayinia S
    BMC Med Genomics; 2022 Nov; 15(1):234. PubMed ID: 36344977
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An intervention strategy to improve genetic testing for dilated cardiomyopathy in a heart failure clinic.
    Mohananey A; Tseng AS; Julakanti RR; Gonzalez-Bonilla HM; Kruisselbrink T; Prochnow C; Rodman S; Lin G; Redfield MM; Rosenbaum AN; Pereira NL
    Genet Med; 2023 Mar; 25(3):100341. PubMed ID: 36472615
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Genetics of dilated cardiomyopathy].
    Osterziel KJ; Scheffold T; Perrot A; Dietz R;
    Z Kardiol; 2001 Jul; 90(7):461-9. PubMed ID: 11515275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.